Home Single cell ribosome profiling for characterizing translation in development, cancer and immunology
Single cell ribosome profiling for characterizing translation in development, cancer and immunology

Single cell ribosome profiling for characterizing translation in development, cancer and immunology

We developed a new ribosome profiling approach that leverages the principles of microfluidics and isotachophoresis: Ribo-ITP (Ozadam et al., Nature):

Previous studies had been restricted to bulk measurements precluding precise determination of translation regulation including allele-specific analyses. To address this challenge, we developed a novel microfluidic isotachophoresis approach, named RIBOsome profiling via IsoTachoPhoresis (Ribo-ITP), and characterized translation in single oocytes and embryos during early mouse development. Our high coverage measurements enabled the first analysis of allele-specific ribosome engagement in early development and led to the discovery of stage-specific differential engagement of zygotic RNAs with ribosomes and reduced translation efficiency of transcripts exhibiting allelic-biased expression. The novel Ribo-ITP approach will enable numerous applications by providing high coverage and high resolution ribosome occupancy measurements from ultra-low input samples including single cells.

We use Ribo-ITP to investigate diverse biological questions, often in close collaboration with domain experts. Recent highlights include:

  1. Characterization of allelic variants in the ribosome biogenesis factor AIRIM in human cerebral organoids (Ni et al., Nature Cell Biology).
  2. Application of Ribo-ITP in C. elegans to map dynamic changes in the translation of maternal mRNAs during the first four cell cycles of embryogenesis (Shukla et al., Cell Reports).
  3. Application of Ribo-ITP to uncover non-canonical translation events in ultra-low-input samples (Ghatpande et al., bioRxiv). Using Ribo-ITP, we profiled ribosome occupancy in microdissected hippocampal tissues and single mouse embryos, revealing thousands of translated short open reading frames (“translons”). Functional assays confirmed translation of selected translons, extending the Ribo-ITP platform to define hidden layers of the translatome in rare cell populations.